A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial.

person Joohyuk Sohn Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea info_outline Joohyuk Sohn, Gun Min Kim, Kyung Hae Jung, Hei-Cheul Jeung, Jieun Lee, Keun Seok Lee, Seock-Ah Im, Seok Yun Kang, Se Hyun Kim, Han Jo Kim, Kyong Hwa Park, Yee Soo Chae, Su-Jin Koh, EUN KYUNG CHO, Keon Uk Park, Sung Sook Lee, Ji-Yeon Kim, In Sil Choi, Sun Kyung Baek, Yong Wha Moon

Authors person Joohyuk Sohn Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea info_outline Joohyuk Sohn, Gun Min Kim, Kyung Hae Jung, Hei-Cheul Jeung, Jieun Lee, Keun Seok Lee, Seock-Ah Im, Seok Yun Kang, Se Hyun Kim, Han Jo Kim, Kyong Hwa Park, Yee Soo Chae, Su-Jin Koh, EUN KYUNG CHO, Keon Uk Park, Sung Sook Lee, Ji-Yeon Kim, In Sil Choi, Sun Kyung Baek, Yong Wha Moon Organizations Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea, Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea, Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea, Center for Breast Cancer, National Cancer Center, Goyang, South Korea, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, South Korea, Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, South Korea, Department of Internal Medicine, Seoul National University, Seoul, Korea, Seongnam, South Korea, Soonchunhyang University Hospital, Cheonan, Chungcheongnam-do, South Korea, Division of Medical Oncology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea, Kyungpook National University Hospital, Daegu, South Korea, Ulsan University Hosp, University of Ulsan, Dong-Gu, South Korea, Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea, Keimyung University Dongsan Medical Hospital, Daegu, South Korea, Inje University Haeundae Paik Hospital, Haeundae-Gu, South Korea, Samsung Medical Center, Seoul, South Korea, Seoul National University Boramae Medical Center, Seoul, South Korea, Kyung Hee University Hospital, Dongdaemun-Gu, Seoul, South Korea, Hematology and Oncology, Internal Medicine Department, CHA Bundang Medical Center, Seongnam, South Korea Abstract Disclosures